These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Krawczyk M; Mykała-Cieśla J; Kołodziej-Jaskuła A Pol Arch Med Wewn; 2009 Mar; 119(3):180-3. PubMed ID: 19514649 [TBL] [Abstract][Full Text] [Related]
45. Hyperpigmented rugosity of skin associated with adenocarcinoma of the caecum. Inamadar AC; Palit A; Yelikar BR Postgrad Med J; 2005 Apr; 81(954):271; quiz 271-2. PubMed ID: 15811897 [No Abstract] [Full Text] [Related]
46. [Malignant acanthosis nigricans: case report and literature review]. Piscoya Rivera A; de los Ríos Senmache R; Valdivia Retamozo J; Cedrón Cheng H; Huerta-Mercado Tenorio J; Bussalleu Rivera A Rev Gastroenterol Peru; 2005; 25(1):101-5. PubMed ID: 15818425 [TBL] [Abstract][Full Text] [Related]
47. [Acanthosis nigricans a sign of malignant cancer proliferation of internal organs]. Jablońska S Pol Tyg Lek; 1965 Sep; 20(36):1355-7. PubMed ID: 5841129 [No Abstract] [Full Text] [Related]
48. Ectodermal dysplasia with acanthosis nigricans (Lelis syndrome). Steiner CE; Cintra ML; Marques-de-Faria AP Am J Med Genet; 2002 Dec; 113(4):381-4. PubMed ID: 12457412 [TBL] [Abstract][Full Text] [Related]
49. Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature. Kebria MM; Belinson J; Kim R; Mekhail TM Gynecol Oncol; 2006 May; 101(2):353-5. PubMed ID: 16443260 [TBL] [Abstract][Full Text] [Related]
50. Acanthosis nigricans and bile duct malignancy. Ravnborg L; Thomsen K Acta Derm Venereol; 1993 Oct; 73(5):378-9. PubMed ID: 7904407 [TBL] [Abstract][Full Text] [Related]
51. Acanthosis nigricans in association with congenital adrenal hyperplasia: resolution after treatment. Case report. Kurtoğlu S; Atabek ME; Keskin M; Canöz O Turk J Pediatr; 2005; 47(2):183-7. PubMed ID: 16052863 [TBL] [Abstract][Full Text] [Related]
52. Treatment of malignant acanthosis nigricans with cyproheptadine. Greenwood R; Tring FC Br J Dermatol; 1982 Jun; 106(6):697-8. PubMed ID: 7082574 [No Abstract] [Full Text] [Related]
54. Ovarian pathology associated with insulin resistance and acanthosis nigricans. Annos T; Taymor ML Obstet Gynecol; 1981 Nov; 58(5):662-4. PubMed ID: 7301247 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of insulin resistance in obese women with and without acanthosis nigricans. Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659 [TBL] [Abstract][Full Text] [Related]
56. [Acanthosis nigricans in patients with stomach cancer]. Zaerko VV Klin Med (Mosk); 1992; 70(5-6):50-2. PubMed ID: 1434403 [No Abstract] [Full Text] [Related]
58. Screening for type 2 diabetes in children with acanthosis nigricans. Hardin DS Diabetes Educ; 2006; 32(4):547-52. PubMed ID: 16873592 [TBL] [Abstract][Full Text] [Related]